As of Mar 27
| +0.0194 / +2.45%|
The 1 analysts offering 12-month price forecasts for LifeVantage Corp have a median target of 1.30, with a high estimate of 1.30 and a low estimate of 1.30. The median estimate represents a +60.53% increase from the last price of 0.81.
The current consensus among 1 polled investment analysts is to Hold stock in LifeVantage Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.